okay so good afternoon to everyone and today's topic is relevant to recent updates from the IC guidelines related to analytical method validation so the Q2 R1 has now become a Q2 R2 so the final version has been adopted by 1st November 2023 and as a part of this video series we'll try to understand what are the updates according to this uh Q2 R2 or the second version of analytical procedure validation the objective of validation is according to the IC is uh to validate the analytical procedure to demonstrate that the analytical procedure is fit for the
intended purpose intended purpose could be a dissolution so you have to demonstrate with the documented evidence that yes my test procedure is why suitable for conducting the dissolution for The Taste product and these are the important uh considerations points we will discuss about um General considerations for analytical procedures validation so this guideline indicates the data which should be presented in a regulatory submissions so you may be submitting your product maybe in USA or maybe in European union or Japan or the countries which are having association with the I so whatever data required according to the
regulatory submissions must be part of your application procedures and this guideline talks about what data should be submitted for analytical procedure method validation means what are the performance characteristics needs to be considered for different types of procedures like for assay what parameters need to be conducted for identification test what parameter needs to be conducted so these performance characteristics are actually part of this guideline and this performance character istics must be submitted during your doer application for those regulatory submissions suitable data derived from development studies can be used as a part of validation data so robustness
parameter or the performance characteristic that need not to be performed exactly during the validation activity but it can be considered from your method development activities and IC q14 talks about the procedure analytical procedure development so in casee if you conducted the robustness study as a part of your design space that same data can be taken for your robustness parameter and that can be reported in your report so you can make a protocol saying that okay for the robustness study uh I am going to take the data from our development report so it is also it
is also been mentioned into the uh icq to R2 now when an established platform analytical procedure is used for a new purpose validation testing can be abbreviated if scientifically Justified example tablets assay method can be used for maybe the blend assay what this indicates if you have the established procedure in the place for existing purpose what is existing purpose is let us say you are having a test procedure for tablet essay and this method is been validated found to be suitable now you also have the blend assay of the for the same product and you
are going to use the same assay test procedure for the blend assay tablets assay procedure is used for the blend assay now in this case your intention intended purpose is common isn't it intended purpose is again the but only now the product stage is different the one stage was finished and another stage is in process now how you can justify the usage of same validation data for the another use like for the blend essay you can say look at my concentration is common my analytical solution concentration is common I'm preparing 100 PPM standard for tablet
essay and I'm also going to prepare 100 PPM during the blend assay analysis my test concentration for tablet assay is 100 PPM and my test concentration for blend ass is also going to be 100 PPM this is one important point the second Point may be the dilution system or the analytical diluant used whatever dilu I have used in tablet assay the similar or the same dial I'm also going to use for the blend assay so in case of you're not going to change any critical chromatographic parameters you need not to perform the complete validation for
the blend essay this is what called as the validation testing can be abbreviated so when you conduct the validation for blend assay by using the tablets assay you are going to Omit some of the parameters like you need not to perform the linearity provided your concentration are similar you need not to perform uh maybe the uh what what you call linearity can be wed up robustness of course you are going to take it from development data or you can take it from your assay validation data you need not to perform maybe uh the force degradation
of course because blend assay is not the uh stability indicating method so in any case the force degradation will not be required but what another parameters can be waved of you can think about uh uh waving of some of the accuracy levels you can just prove that yes my method is accurate at at the highest lowest and the optimum concentrations during the while I have conducted the ass validation maybe 80% 100% And 120% but during the blend assay validation you can only conduct the accuracy at only 100% And you can wave of 80% and 120%
accuracy you can also wave up uh another parameters like maybe solution stability mobile phase stability maybe the filter compatibility provided your concentration is common and the same so what parameters you are going to perform very minimum parameters like maybe the placebo interference diluent interference maybe accuracy at 100% And the Precision and maybe intermediate Precision that's it you need to perform during the blend essay so this is called as abbreviated value validation now and it is based onto the assay tablet assay method validation so you have validated the uh tablet as a method and as you
Justified with the scientific rationals you can go with the minimum uh only spe specific required parameter during the blend as validation approaches other than those set forth in this guideline may be applicable and acceptable with appropriate science based justification so there are number of performance character ICS like specificity linearity Precision Etc and this guideline talks about how to conduct the specificity how to conduct Precision now it is not always a mandatory that you have to follow the same recommended procedures you can also switch to another procedures by giving the appropriate science based justifications it could
be about how you are going to perform Precision for a contain uniformity of the dosage you know you are going going to make six preparations or 10 preparations so those differences also can be justified maybe based on to your specification requirement so the different procedures can be adopted provided you have some scientific rals for that the applicant is responsible for Designing the validation studies and protocol most suitable for their product see it's your product it is your procedures and you know better what are the challenges what are the critical points what are the weaknesses of
the test procedures and based onto that we can certainly Define the protocol but protocol should be defined by putting the uh what do you call uh what is going to be the worst result if I follow these parameters and that is the way that you're going to challenge your testing procedures it is going to be a biased protocol it is going to be a biased posi purpose F to challenge the procedure and then understand look at here now I was biased at the worst case situations or scenarios but in spite of that I'm still able
to achieve my Precision accuracy specificity all that so that way the applicant should design the protocol by keeping in the mind what can worse happen to my test procedures how I can able to get the probabil the worst validation result and looking at those you have to define the protocols and this will also help you that okay if I go with the worst situations I'm still able to achieve the desired characteristics of precision linearity accuracy and specificity Etc the protocol should contain information about the intended purpose of the analytical procedure the performance characteristics to be
validated and the associated criteria so protocol is the guidance document on performing the validation so what is the intended purpose of analytical procedure that is the first important point this test procedure is valid should be validated for ass say for a paracetamol tablet or related substances of paracetamol in a paracetamol tablet that is the intended purpose the performance characteristics to be validated so as a part of related substances validation what are the performance characteristics means validation parameters need to be performed so those parameters needs to be listed and you need to also give the details
of the preparation of analytical Solutions associated with each and every performance parameters or performance characteristics and also give the associated criterias you know what is going to be my acceptance criterias for precision what is going to be my acceptance criterias for linearity so all those acceptance criterias must and should be part of your protocol if Justified it may be acceptable to perform some validation test using a different number of replicates or to adjust the number of replicates in the analytical procedure Based on data generated during validation I think we talked about content uniformity of dosage
or U dosage unit uniformity of dosage isn't it so in that case we may perform 10 preparations for a Precision may not be six so those number of replicates preparations can be changed replicates uh yes you can also have maybe five replicates as a part of system Precision if you don't want to go with the six replicates so those details can be proposed and based onto the outcome as a part of validation you can always propose the replicates in the future course of your testing procedures that yes system suitability can be assisted Maybe by five
preparations and not six preparations maybe system suitability can be assessed Maybe by nine preparations and not by the six preparations so those changes in the replicates always can be pre uh you know uh proposed that can be tested as a part of your validation plan and then you can certainly confirm that whether it is suitable or not reference materials or other suit suitably characterized materials with documented identity Purity or any other characteristics as necessary should be used in the validation study so you're going to perform the tress of your analytical procedures and how you can
confirm the tress or accuracy It Is by comparing the test results maybe with the help of valid with the help of you know the valid reference materials how much you spike how much you recovered and to understand that you should have a reference material with the known potency or the Purity so you should have the validated reference standard with the certificate of analysis fully characterized working standard also can be used as described in the iq4 the system suitability test that is SST is an integral part of analytical procedures and is generally established during development as
a regular check of performance the system suitability is going to help you to define whether my system is suitable or not isn't it unless and until your system that you are going to use for validation is suitable how you going to confirm that whatever variations you is getting not is only because of the analytical procedure not because of the system you're using you must be removing or you must be confirming that variation is not because of my system my system is not the limiting parameter my system is not limiting the performance of the test procedure
so for understanding whether your system is not limiting the performance of the test procedure you must have the system suitability test that my HC my gas chromatography my dissolution my C hydrator is suitable for any kind of the test procedure and then if there are some variations coming now whose fault is this now because you have performed the system suitability test and system found to be suitable so if anything goes wrong it may be the because of the fault of your testing procedure so SST is the integral part of your analytical test procedure according to
the iq4 and everyone has to perform the system suitability as a regular check while during validation and also during your routin testing robustness is typically evaluated as a part of development prior to the execution of the analytical procedure validation study so we talked about that robustness can be taken from the your iq4 uh during your method development study right so you can take the same data from development and you can report in the validation report so this is all about you know what general considerations you need to uh uh Define while performing your validation study
as a part of this uh series of the video we will also try to understand the next part of the I method validation guideline that is Q2 R2 thank you so much